Concepedia

Author

Luis Moltó

Hospital Universitario Príncipe de Asturias

Also Known As

L M Moltó, L Molto, L Moltó, L. MOLTó, L. Molto, L.M. Moltó, LUIS MOLTÓ, Luis M. Moltó, Luis Molto, Luis Moltó

29

Publications

647

Citations

13

H-Index

26

Concepts

All Affiliations

Hospital Universitario Príncipe de AsturiasCleveland ClinicUniversidad de AlcaláCerner (United States)Cleveland Clinic Lerner College of Medicine
LM

About

Luis Moltó is an author at Hospital Universitario Príncipe de Asturias specializing in medicine, tumor microenvironment, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

239

2

Immunology

3

3

203

3

Pathology

3

3

67

4

Cell Biology

2

2

190

5

Surgical Oncology

1

1

25

Luis Moltó

×

17

Publications

602

Citations

13

H-Index

YearCitations

Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.

Robert G. Uzzo, Patricia Rayman, Vladimir Kolenko,

PubMed

1999

147

Clinical and Immunologic Effects of Subcutaneously Administered Interleukin-12 and Interferon Alfa-2b: Phase I Trial of Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma

Gheath Alatrash, Thomas E. Hutson, Luis Moltó,

Journal of Clinical Oncology

2004

80

Degradation of NF-κB in T Cells by Gangliosides Expressed on Renal Cell Carcinomas

Mark Thornton, Daisuke Kudo, Patricia Rayman,

The Journal of Immunology

2004

52

Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.

Ronald M. Bukowski, Patricia Rayman, Luis Moltó,

PubMed

1999

43

Renal Cell Carcinoma Tumors Induce T Cell Apoptosis through Receptor-Dependent and Receptor-Independent Pathways

Tanya Das, Gaurisankar Sa, Ewa Paszkiewicz‐Kozik,

The Journal of Immunology

2008

42

GM1 and Tumor Necrosis Factor-α, Overexpressed in Renal Cell Carcinoma, Synergize to Induce T-Cell Apoptosis

Tanya Das, Gaurisankar Sa, Cynthia Hilston,

Cancer Research

2008

37

Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.

Patricia Rayman, Robert G. Uzzo, Vladimir Kolenko,

PubMed

2000

37

Hemolytic anemia in chronic large granular lymphocytic leukemia of natural killer cells: Cytotoxicity of natural killer cells against autologous red cells is associated with hemolysis

F. Gilsanz, Javier de la Serna, Luis Moltó,

Transfusion

1996

25

Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation

Luis Moltó, Melchor Álvarez‐Mon, Joaquı́n Carballido,

British Journal of Cancer

1994

25

Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder

Joaquı́n Carballido, Luis Moltó, Luís Manzano,

Cancer

1993

21

Page 1